{
    "clinical_study": {
        "@rank": "117542", 
        "arm_group": [
            {
                "arm_group_label": "Patients of palmer arsenical keratosis", 
                "arm_group_type": "Experimental", 
                "description": "One soft capsule of garlic oil (10 mg) daily for 12 weeks"
            }, 
            {
                "arm_group_label": "Arsenic exposed controls", 
                "arm_group_type": "Active Comparator", 
                "description": "One soft capsule of garlic oil (10 mg) daily for 12 weeks"
            }, 
            {
                "arm_group_label": "Heathy volunteers", 
                "arm_group_type": "Active Comparator", 
                "description": "One soft capsule of garlic oil (10 mg) daily for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated\n      with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body\n      arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed\n      controls and healthy volunteers will be included for comparison."
        }, 
        "brief_title": "Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis", 
        "completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "condition": "Chronic Arsenic Poisoning", 
        "condition_browse": {
            "mesh_term": [
                "Keratosis", 
                "Keratosis, Actinic", 
                "Poisoning", 
                "Arsenic Poisoning"
            ]
        }, 
        "detailed_description": {
            "textblock": "Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and\n      soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition.\n      Till today there is no effective treatment.\n\n      Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated\n      with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be\n      given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of\n      this study is to examine the effectiveness of oral administration of garlic oil to reduce\n      body arsenic load and clinical symptoms of arsenical palmer keratosis."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria (Patients):\n\n          -  history of taking arsenic contaminated water (>50 ppb) for more than 6 months\n\n          -  patients having mild to moderate arsenical keratosis present on palm of the hand\n\n          -  patients those voluntarily agree to participate\n\n        Inclusion Criteria (Arsenic exposed controls):\n\n          -  family member of the patient\n\n          -  drinking arsenic contaminated water from the same source as patient\n\n          -  those voluntarily agree to participate\n\n          -  no sign/symptom of palmer keratosis\n\n        Inclusion Criteria (Healthy volunteers):\n\n          -  drinking arsenic safe water (<50 ppb)\n\n          -  those voluntarily agree to participate\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  lactating mother\n\n          -  patient receiving treatment of arsenicosis\n\n          -  any other chronic disease like tuberculosis, diabetes mellitus, bronchial asthma"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 11, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01748669", 
            "org_study_id": "BSMMU-005-CT"
        }, 
        "intervention": {
            "arm_group_label": [
                "Patients of palmer arsenical keratosis", 
                "Arsenic exposed controls", 
                "Heathy volunteers"
            ], 
            "description": "Oral administration", 
            "intervention_name": "Garlic oil", 
            "intervention_type": "Dietary Supplement"
        }, 
        "intervention_browse": {
            "mesh_term": "Allyl sulfide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Arsenic", 
            "Arsenicosis", 
            "Garlic oil", 
            "Keratosis"
        ], 
        "lastchanged_date": "December 11, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Dhaka", 
                    "country": "Bangladesh"
                }, 
                "name": "Bangabandhu Sheikh Mujib Medical University"
            }
        }, 
        "location_countries": {
            "country": "Bangladesh"
        }, 
        "number_of_arms": "3", 
        "official_title": "Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer Keratosis", 
        "overall_official": {
            "affiliation": "Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.", 
            "last_name": "Mir Misbahuddin, MBBS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bangladesh: Ethical Review Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Change in the clinical symptom of keratosis in palm", 
            "safety_issue": "No", 
            "time_frame": "0 week (baseline) to 12 weeks (end)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01748669"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
            "investigator_full_name": "Prof. Mir Misbahuddin", 
            "investigator_title": "Prof. and Chairman, Department of Pharmacology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in biochemical parameters (blood sugar, cholesterol and transaminase) after treatment", 
                "safety_issue": "Yes", 
                "time_frame": "0 week (baseline), 12 weeks (end)"
            }, 
            {
                "measure": "Adverse effects following treament", 
                "safety_issue": "Yes", 
                "time_frame": "0 week (baseline), 12 weeks (end)"
            }, 
            {
                "measure": "Change in the amount of arsenic in nail", 
                "safety_issue": "No", 
                "time_frame": "0 week (baseline), 20 weeks (end)"
            }
        ], 
        "source": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}